BIO-BBIO-BNYSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank86
3Y CAGR+0.2%
5Y CAGR+2.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+0.2%/yr
vs +3.8%/yr prior
5Y CAGR
+2.3%/yr
Consistent
Acceleration
-3.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$1.24B+4.7%
2024$1.19B-4.6%
2023$1.24B+0.8%
2022$1.23B-3.9%
2021$1.28B+16.0%
2020$1.11B+5.0%
2019$1.05B-1.0%
2018$1.07B+9.6%
2017$972.75M+4.6%
2016$930.09M-